Gout, urate-lowering therapy, and uric acid levels among adults in the United States
about
Review: Gout: A Roadmap to Approaches for Improving Global OutcomesGout treatment: survey of Brazilian rheumatology residents.Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical TrialDisease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisDASH diet and change in serum uric acid over time.Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.Severe tophaceous gout and disability: changes in the past 15 years.Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat.Effects of a DASH Diet Intervention on Serum Uric Acid in African Americans with Hypertension.Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout.Pilot study of a multidisciplinary gout patient education and monitoring program.How Can We Improve Disease Education in People with Gout?
P2860
Q28076018-E98D9632-4A99-4FAE-93CE-96EA6670DC1DQ30238939-C44B47A2-BD4A-427B-9F86-98D1F1444026Q35746133-198CAA24-A7E5-4A5A-B496-247270F4880AQ37191351-84F8E9A5-F0A6-4034-BE4E-CF5C273848C1Q37208467-B320AAF8-E222-4980-AA88-E8AB87EF641EQ38865581-2024F19F-D355-4F8A-AD3F-1CFC8A1F2249Q38935307-BE0BFF66-844D-4262-A2E3-29196D4F64F3Q39386597-94C9A7B5-12D6-44C6-BE2B-DA991CCC9811Q39741682-932EB389-505B-4F8D-AA67-1347822EB7E3Q40075226-FFF0CE6A-CB13-4A87-8E99-0AC830D5F0DEQ40311349-F0AC3670-6916-4278-A3F3-8032D3D69E38Q42688139-6F6117AC-2A31-435D-9A07-9225830E5E7EQ47727483-E2717E04-1558-4A2F-9B33-94C62CB273ABQ47749212-998AB17C-0FAF-4DA3-8EA5-D01F4B4146C0Q50111167-C837E9AF-75BE-4E2F-805D-9FF1E5C5ECFCQ52667810-8C973221-7101-4328-924E-B292E7507538
P2860
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@ast
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@en
type
label
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@ast
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@en
prefLabel
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@ast
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@en
P2093
P2860
P356
P1476
Gout, urate-lowering therapy, and uric acid levels among adults in the United States
@en
P2093
Allan C Gelber
Edgar R Miller
Lara C Kovell
P2860
P304
P356
10.1002/ACR.22469
P577
2015-04-01T00:00:00Z